Related Experiment Video
Updated: Jun 7, 2025
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
18.9K
[Hereditary thrombophilia; whom to test?]
Kyra N Smit1,2, Henrike M Hamer1, Irene L M Klaassen3
1Amsterdam UMC, Amsterdam. Afd. Laboratoriumgeneeskunde.
Nederlands Tijdschrift Voor Geneeskunde
|November 13, 2024
Summary
Thrombophilia testing aids in diagnosing hereditary conditions linked to venous thromboembolism (VTE). However, testing is recommended only for specific patients where results will guide treatment decisions.
Area of Science:
- Hematology
- Genetics
Background:
- Thrombophilia, a hemostatic system disturbance, increases venous thromboembolism (VTE) risk.
- Most guidelines do not recommend thrombophilia testing for most VTE patients due to limited impact on treatment decisions.
Purpose of the Study:
- To describe two cases where hereditary thrombophilia testing was considered.
- To highlight specific patient populations who may benefit from thrombophilia testing.
Main Methods:
- Case report review.
- Analysis of clinical decision-making processes regarding hereditary thrombophilia testing.
Main Results:
- Identified specific clinical scenarios where hereditary thrombophilia testing is valuable.
- Emphasized the importance of pre-determined treatment strategies based on test outcomes.
Conclusions:
- Hereditary thrombophilia testing should be reserved for select VTE patients.
- Testing decisions must be guided by how results will influence future clinical management and treatment.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
01:24Disorders of Hemostasis
711
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
711
01:49Probability Laws
40.2K
Overview
40.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.7K
01:35Pedigree Analysis
84.0K
Overview
84.0K